PBD Biotech

Thurston, United Kingdom Founded: 2014 • Age: 12 yrs
Developer of diagnostic test to detect Mycobacterium in bovines

About PBD Biotech

PBD Biotech is a company based in Thurston (United Kingdom) founded in 2014.. PBD Biotech has raised $6.36 million across 5 funding rounds from investors including Mercia, The University of Nottingham and Foresight Group. PBD Biotech offers products and services including Actiphage. PBD Biotech operates in a competitive market with competitors including OpGen, QuantuMDx, Oxford Immunotec, Avails Medical and Resistell, among others.

  • Headquarter Thurston, United Kingdom
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Pbd Biotech Limited
  • Date of Incorporation 17 Feb, 2014
  • Jurisdiction BIRMINGHAM, WEST MIDLANDS, ENGLAND
Operational Areas
Healthcare → Veterinary & Animal Health
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $6.36 M (USD)

    in 5 rounds

  • Latest Funding Round
    $2.68 M (USD), Series B

    Oct 17, 2022

  • Investors
    Mercia

    & 7 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of PBD Biotech

PBD Biotech offers a comprehensive portfolio of products and services, including Actiphage. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Detects mycobacteria in blood samples for tuberculosis diagnosis.

People of PBD Biotech
Headcount 1-10
Employee Profiles 5
Board Members and Advisors 8
Employee Profiles
People
Douglas McKechnie
Quality Assurance Manager
People
Maddy Kennedy
Interim CFO
People
Mondana Cook
COO
People
Jonnie Yewdall
Chief Commercial Officer, UK & International

Unlock access to complete

Board Members and Advisors
people
Geoff Gower
Board Member
people
Delia Goletti
Advisor
people
Robert Price-Jones
Advisor
people
Sandy Reid
Board Member

Unlock access to complete

Funding Insights of PBD Biotech

PBD Biotech has successfully raised a total of $6.36M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $2.68 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Series B — $2.7M
  • First Round
  • Investors Count 8
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2022 Amount Series B - PBD Biotech Valuation Mercia , Foresight Group
Mar, 2021 Amount Series A - PBD Biotech Valuation Mercia , Foresight Group
Aug, 2018 Amount Seed - PBD Biotech Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in PBD Biotech

PBD Biotech has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Mercia, The University of Nottingham and Foresight Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investment funding is provided to support Midlands SMEs growth.
Founded Year Domain Location
-
Founded Year Domain Location
Investment support is provided for agritech startups in the UK.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by PBD Biotech

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - PBD Biotech

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Pbd Biotech Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of PBD Biotech

PBD Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OpGen, QuantuMDx, Oxford Immunotec, Avails Medical and Resistell, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of diagnostics and bioinformatics platforms for providers
domain founded_year HQ Location
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
domain founded_year HQ Location
Immune markers are utilized by Oxford Immunotec for disease diagnostics.
domain founded_year HQ Location
Point-of-care devices are developed for infection diagnosis and treatment optimization.
domain founded_year HQ Location
Antibiotic susceptibility testing is provided via bacterial movement detection.
domain founded_year HQ Location
Develops rapid assay medical tests that use a single drop of blood to test for a variety of common conditions, illnesses and diseases
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Pbd Biotech

Frequently Asked Questions about PBD Biotech

When was PBD Biotech founded?

PBD Biotech was founded in 2014 and raised its 1st funding round 3 years after it was founded.

Where is PBD Biotech located?

PBD Biotech is headquartered in Thurston, United Kingdom. It is registered at Thurston, Suffolk, United Kingdom.

Is PBD Biotech a funded company?

PBD Biotech is a funded company, having raised a total of $6.36M across 5 funding rounds to date. The company's 1st funding round was a Seed of $518.37K, raised on Aug 24, 2017.

What does PBD Biotech do?

PBD Biotech was founded in 2014 in Thurston, United Kingdom, within the biotechnology sector focused on veterinary diagnostics. Tests to detect active tuberculosis infections in bovines are provided through the Actiphage blood test, which relies on phage-based detection methods. Operations center on developing and offering these diagnostic solutions for animal health monitoring in the agricultural industry.

Who are the top competitors of PBD Biotech?

PBD Biotech's top competitors include QuantuMDx, Avails Medical and OpGen.

What products or services does PBD Biotech offer?

PBD Biotech offers Actiphage.

Who are PBD Biotech's investors?

PBD Biotech has 8 investors. Key investors include Mercia, The University of Nottingham, Foresight Group, Midlands Engine Investment Fund, and Future Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available